Entera Bio Ltd.
ENTX
$2.06
-$0.16-7.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.48% | -3.47% | -8.86% | 21.95% | -40.84% |
| Total Depreciation and Amortization | 14.29% | -12.50% | -27.27% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 69.68% | -11.50% | 2.56% | -37.23% | 57.17% |
| Change in Net Operating Assets | -143.33% | -12.25% | 88.14% | 488.16% | -136.89% |
| Cash from Operations | -53.40% | -16.17% | 4.29% | 31.89% | -61.35% |
| Capital Expenditure | -48.28% | -262.50% | -166.67% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -48.28% | -262.50% | -166.67% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 945.83% | -99.82% | 282.01% | 27,130.77% | -98.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.67% | 59.68% | 42.41% | -- | 100.00% |
| Cash from Financing | 590.20% | -100.38% | 314.58% | 24,646.15% | -98.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -32.44% | -114.35% | 582.60% | 181.60% | -1,699.16% |